NASDAQ:OPRX OptimizeRx Q3 2026 Earnings Date & Estimates $8.28 -0.10 (-1.19%) Closing price 10/9/2026 04:00 PM EasternExtended Trading$8.28 +0.01 (+0.06%) As of 10/9/2026 07:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. OptimizeRx is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. The conference call is scheduled for 4:30 PM ET. Research:ProfileEarnings HistoryForecast Upcoming Earnings Announcement QuarterQ3 2026Announcement DateNovember 5, 2026TimeAfter Market ClosesConference Call4:30 PM ET Add to CalendarGoogle Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab) What Analysts Expect from OptimizeRx in Q3 2026OptimizeRx is expected to post earnings of $0.18 per share on revenue of $21.19 million. In the same quarter a year earlier OptimizeRx reported $0.20 per share on revenue of $26.07 million. OptimizeRx last reported on August 12, 2026, posting $0.16 per share and beating the $0.1111 consensus estimate. OptimizeRx has beaten the consensus EPS estimate in 7 of its last 8 quarters.Consensus EstimatesConsensus EPS$0.18Expected Revenue$21.19 millionPrior-Year EPS$0.20Prior-Year Revenue$26.07 millionExpected EPS Growth-10.0%Expected Revenue Growth-18.7%Recent Track RecordLast ReportedQ2 2026Last Quarter EPS$0.16 (Beat by +$0.0489)Last Quarter Revenue$20.50 millionEPS Beat Rate7 of last 8 quartersPrepare for the Q3 2026 CallEarnings HistoryCompany ProfileQ2 2026 Earnings ReportQ1 2026 Earnings ReportQ4 2025 Earnings Report OptimizeRx Q3 2026 Earnings FAQ When does OptimizeRx report Q3 2026 earnings? OptimizeRx (NASDAQ:OPRX) is scheduled to report Q3 2026 earnings on Thursday, November 5, 2026, after market closes. What time is OptimizeRx's Q3 2026 earnings call? OptimizeRx's Q3 2026 earnings conference call is scheduled for Thursday, November 5, 2026 at 4:30 PM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date. What is the consensus EPS estimate for OptimizeRx? Analysts expect OptimizeRx to post earnings of $0.18 per share for Q3 2026. How much revenue is OptimizeRx expected to report? The consensus revenue estimate for OptimizeRx is $21.19 million for Q3 2026. OptimizeRx Earnings HeadlinesTeladoc Health (NYSE:TDOC) and OptimizeRx (NASDAQ:OPRX) Head-To-Head ContrastOctober 8 at 4:59 AM | americanbankingnews.comOptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, B. Riley Financial Analyst SaysOctober 1, 2026 | americanbankingnews.comThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are triggering a historic wealth transfer already underway in 2026. Household names like Intuit (-57%), Boston Scientific (-49%), and Tractor Supply (-40%) are cratering, while lesser-known companies like Sandisk (+573%) and Rackspace (+444%) surge. Chaikin has identified specific stocks he believes investors should sell before they fall further - and the names may surprise you. He's also pinpointing a company tapped as Nvidia's self-driving partner and a potential AI megadeal that could split into three high-growth stocks. Stream his free presentation to get every buy and sell recommendation with no membership or credit card required.October 10 at 1:00 AM | Chaikin Analytics (Ad)SOPHiA GENETICS (NASDAQ:SOPH) & OptimizeRx (NASDAQ:OPRX) Head to Head ReviewSeptember 29, 2026 | americanbankingnews.comOptimizeRx Corp. And The Trade Desk Bring Net New Authenticated HCP Reach To The Trade Desk Through OpenPathSeptember 22, 2026 | marketscreener.comMOptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPathSeptember 22, 2026 | globenewswire.comSee More OptimizeRx Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like OptimizeRx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on OptimizeRx and other key companies, straight to your email. Email Address About OptimizeRxOptimizeRx (NASDAQ:OPRX) Corporation is a digital health company that provides technology and communication solutions for the life sciences and healthcare industries. Its platform connects pharmaceutical and biotechnology companies with healthcare providers and patients through digital channels integrated into electronic health records, electronic prescribing systems and other clinical workflows. The company’s solutions support activities such as delivering treatment information, patient savings and affordability offers, medication adherence programs, and other communications intended to help patients access and remain on prescribed therapies. OptimizeRx also provides tools designed to help life sciences companies engage healthcare professionals, support product education and generate insights from healthcare data. Founded in 2006, OptimizeRx has primarily served the U.S. healthcare market, working with pharmaceutical manufacturers, biotechnology companies, healthcare providers and technology partners. The company is headquartered in Michigan and has historically been led by co-founder and Chief Executive Officer William J. Febbo.View OptimizeRx ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 10/05 - 10/09Delta Air Lines Faces a Fuel Crisis—But There's a Silver LiningPalantir’s Rally Puts Wall Street in Catch-Up Mode Ahead of November EarningsApplied Digital’s Hidden Moat Could Unlock Massive UpsideLevi's Stock Dip Reveals Value Opportunity Despite Q3 HeadwindsTilray Finds a Path to Growth Without Waiting on U.S. Cannabis ReformPepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value Upcoming Earnings Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026)Wells Fargo & Company (10/13/2026)Johnson & Johnson (10/13/2026)UnitedHealth Group (10/13/2026)Bank of America (10/14/2026)BlackRock (10/14/2026)Morgan Stanley (10/14/2026)Progressive (10/14/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
